|
|
Vol. 11.11 – 30 June, 2025
|
|
|
|
|
|
|
|
Researchers identified receptor-interacting serine/threonine kinase 4 (RIPK4) as an alternative upstream kinase of LATS1/2 in the Hippo pathway through screening a kinome library. [Developmental Cell]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
DERMAL STEM CELLS & TISSUE REGENERATION
|
|
|
|
|
|
The authors investigated the involvement of epidermal keratinocytes in rabies virus (RABV) entry. RABV antigen was detected in keratinocytes at inoculation sites in experimentally infected mice and at potential viral entry sites in naturally infected dogs.
[npj Viruses]
|
|
|
|
|
|
Scientists evaluated TT-012 and found that most BRAFWT melanoma lines are resistant to TT-012 due to low microphthalmia transcription factor (MITF) transcriptional activity and reduced dependency on MITF for proliferation. [Acta Pharmacologica Sinica]
|
|
|
|
|
|
Investigators established that dendritic Merkel cells express atonal homolog 1a (atoh1a), extend dynamic filopodial processes, and arise in transient waves during zebrafish skin development and regeneration.
[Development]
|
|
|
|
|
|
|
|
Scientists showed that similar tumors can arise in albino mice bearing only a Braf mutation. Incidence kinetics suggested a stochastic event underlies tumorigenesis in tumors that arise with only a Braf mutation. [Nature Communications]
|
|
|
|
|
|
The expression of CDKL3 was revealed using clinical human malignant melanoma tissues and normal skin tissues. [Molecular Carcinogenesis]
|
|
|
|
|
|
|
|
|
The authors contextualize the emergence of ipilimumab and nivolumab in the adjuvant and neo-adjuvant treatment of resectable stage III melanoma with discussion of pivotal studies, and how they influence the current guidelines. [Expert Review of Anticancer Therapy]
|
|
|
|
|
|
|
|
Scinai Immunotherapeutics Ltd. announced that Dr. Roberta Lotti has received the prestigious “Oscar of Italian Dermatology” from SIDeMaST, the Italian Society of Dermatology and Venereology. [Scinai Immunotherapeutics Ltd.]
|
|
|
|
|
|
|
|
July 15-17, 2025 Boston, Massachusetts, United States
|
|
|
|
|
|
|
|
|
|
|
Howard Hughes Medical Institute (HHMI) – New York City, New York, United States
|
|
|
|
|
|
|
Edith Cowan University – Joondalup, Australia
|
|
|
|
|
|
|
The Ohio State University – Columbus, Ohio
|
|
|
|
|
|
|
Duke University – Durham, North Carolina, United States
|
|
|
|
|
|
|
University of British Columbia – Vancouver, British Columbia, Canada
|
|
|
|
|
|